Log In
BCIQ
Print this Print this
 

BMS-754807

  Manage Alerts
Collapse Summary General Information
Company Bristol-Myers Squibb Co.
DescriptionInsulin-like growth factor-1 (IGF-1) receptor (IGF1R) antagonist
Molecular Target Insulin-like growth factor-1 (IGF-1) receptor (IGF1R) (CD221)
Mechanism of ActionInsulin-like growth factor-1 (IGF-1) receptor antagonist
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced or metastatic solid tumors
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today